Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
AssigneeSloan-Kattering Institute For Cancer Research
InventorsPaul B. Chapman, Alan N. Houghton
Life of this patent
Estimating the term…
Abstract
The present invention provides an anti-idiotypic monoclonal antibody which specifically induces an immune response against a glycosphingolipid. Additionally, this invention provides a method of producing the anti-idiotypic monoclonal antibody. Finally, this invention provides a composition of matter comprising an effective amount of a cytokine and a melanoma ganglio-side-specific antibody attached to a carrier.
Claims1
A method for generating in a subject an immune response against ganglioside GD3 by administering to the subject anti-idiotypic antibody BEC-2 (ATCC No. HB 10153).
Dependencies are inferred from the claim text.